Benzothiadiazine suppression of insulin release from normal and abnormal islet tissue in man.
Year: 1966
Type: article
Abstract: The diabetogenic activity of benzothiadiazine drugs has been well established (2). Diazoxide 1 is an antihypertensive agent with potent hypergly-cemic activity, particularly when used in combina-tion with trichlormethiazide 2 (3-5). The mode of action by which these compounds exert a tem-porary diabetogenic effect has not been established. It has been suggested by some that diazoxide-in-duced hyperglycemia may result from inhibition of insulin release. Samaan, Dollery, and Fraser found that insulin-like activity (both "typical " and "atypical") as measured by the epididymal fat pad technique was lower in four diabetic patients taking thiazides than in normal subjects (6). Within 3 to 26 weeks after thiazides were discon-
DOI: 10.1172/jci105362
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2054811823
